Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
CALL
Voya Financial
VOYA
$9.13B
| $3.48M | ﹤0.01% |
59,100
+36,400
| +160% | +$1.97M |
|
4202
PUT
BJ's Restaurants
BJRI
$1.41B
| $3.47M | ﹤0.01% |
90,200
-69,600
| -44% | -$2.37M |
|
4203
Mesa Laboratories
MLAB
$605M
| $3.47M | ﹤0.01% |
12,091
+6,877
| +132% | +$1.89M |
|
|
EV
4204
DELISTED
Eaton Vance Corp.
EV
| $3.46M | ﹤0.01% |
50,953
-1,580,529
| -97% | -$98.7M |
|
4205
PUT
Brighthouse Financial
BHF
$3.27B
| $3.46M | ﹤0.01% |
95,600
-100,100
| -51% | -$3.36M |
|
4206
Yext
YEXT
$581M
| $3.46M | ﹤0.01% |
220,071
-140,330
| -39% | -$2.4M |
|
4207
PUT
Outfront Media
OUT
$5.24B
| $3.45M | ﹤0.01% |
179,421
+65,937
| +58% | +$1.11M |
|
4208
GoodRx Holdings
GDRX
$1.26B
| $3.45M | ﹤0.01% |
85,563
-17,899
| -17% | -$822K |
|
4209
Invesco BulletShares 2028 High Yield Corporate Bond ETF
BSJS
$744M
| $3.45M | ﹤0.01% |
133,910
+42,905
| +47% | +$1.08M |
|
4210
Dorman Products
DORM
$4.02B
| $3.45M | ﹤0.01% |
39,736
-49,999
| -56% | -$4.63M |
|
4211
SM Energy
SM
$8.28B
| $3.45M | ﹤0.01% |
563,508
+494,992
| +722% | +$1.67M |
|
|
CSII
4212
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.45M | ﹤0.01% |
78,812
-443,603
| -85% | -$16.7M |
|
4213
FirstService
FSV
$6.11B
| $3.45M | ﹤0.01% |
25,215
-14,666
| -37% | -$1.98M |
|
4214
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.42B
| $3.45M | ﹤0.01% |
33,770
-126,056
| -79% | -$12.9M |
|
|
KALV
4215
PUT
DELISTED
KalVista Pharmaceuticals
KALV
| $3.44M | ﹤0.01% |
+181,400
| New | +$3.11M |
|
4216
C4 Therapeutics
CCCC
$514M
| $3.44M | ﹤0.01% |
+103,873
| New | +$3.01M |
|
|
GWPH
4217
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.44M | ﹤0.01% |
29,806
-72,591
| -71% | -$8.13M |
|
|
MIC
4218
CALL
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $3.44M | ﹤0.01% |
91,500
-43,000
| -32% | -$1.32M |
|
4219
CALL
Targa Resources
TRGP
$59.2B
| $3.44M | ﹤0.01% |
130,200
+6,100
| +5% | +$130K |
|
4220
CALL
Hecla Mining
HL
$12.7B
| $3.43M | ﹤0.01% |
530,000
-44,100
| -8% | -$235K |
|
4221
Innoviva
INVA
$1.51B
| $3.43M | ﹤0.01% |
276,941
-90,151
| -25% | -$972K |
|
|
SRTA
4222
Strata Critical Medical Inc
SRTA
$520M
| $3.43M | ﹤0.01% |
+309,421
| New | +$3.16M |
|
4223
Helmerich & Payne
HP
$4.43B
| $3.43M | ﹤0.01% |
147,953
-426,151
| -74% | -$8.26M |
|
4224
Banco Santander
SAN
$207B
| $3.42M | ﹤0.01% |
1,120,349
-256,546
| -19% | -$649K |
|
4225
Pennant Group
PNTG
$1.37B
| $3.42M | ﹤0.01% |
58,842
-37,385
| -39% | -$1.8M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.